Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Breast Neoplasms 3135Neoplasms 2480Carcinoma, Non-Small-Cell Lung 1877Prostatic Neoplasms 1635Colorectal Neoplasms 1422Lung Neoplasms 1308Multiple Myeloma 935Neoplasm Metastasis 927Leukemia, Myeloid, Acute 883Pancreatic Neoplasms 861Ovarian Neoplasms 811Melanoma 792Carcinoma, Hepatocellular 739Stomach Neoplasms 649Brain Neoplasms 638Squamous Cell Carcinoma of Head and Neck 637Recurrence 637Head and Neck Neoplasms 606Glioblastoma 569Lymphoma 550Uterine Cervical Neoplasms 544Triple Negative Breast Neoplasms 514Precursor Cell Lymphoblastic Leukemia-Lymphoma 514Carcinoma, Renal Cell 504Hematologic Neoplasms 464Endometrial Neoplasms 463Urinary Bladder Neoplasms 462Colonic Neoplasms 446Lymphoma, Non-Hodgkin 437Sarcoma 435

Interventions

ceftolozane, tazobactam drug combination 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pseudomonas Infections × 1 year × Clear all
NCT04673175 2026-01-21

Ceftolozane-Tazobactam for Directed Treatment of Pseudomonas Aeruginosa Bacteremia and Pneumonia in Patients With Hematological Malignancies and Hematopoietic Stem Cell Transplantation

Weill Medical College of Cornell University

Phase 4 Terminated
17 enrolled 20 charts
Other hematologic neoplasm

Pneumonia, Pseudomonas Infections, Bacteremia, Gram-Negative Bacterial Infections, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡